Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017033966) 5-CARBONYLAMINOALKYL-SUBSTITUTED FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/033966 International Application No.: PCT/JP2016/074650
Publication Date: 02.03.2017 International Filing Date: 24.08.2016
IPC:
C07D 487/04 (2006.01) ,A61K 31/4985 (2006.01) ,A61P 9/10 (2006.01) ,A61P 11/00 (2006.01) ,A61P 13/00 (2006.01) ,A61P 13/12 (2006.01) ,A61P 17/00 (2006.01) ,A61P 17/02 (2006.01) ,A61P 19/02 (2006.01) ,A61P 25/04 (2006.01) ,A61P 29/00 (2006.01) ,A61P 35/00 (2006.01) ,A61P 37/06 (2006.01) ,A61P 43/00 (2006.01)
[IPC code unknown for C07D 487/04][IPC code unknown for A61K 31/4985][IPC code unknown for A61P 9/10][IPC code unknown for A61P 11][IPC code unknown for A61P 13][IPC code unknown for A61P 13/12][IPC code unknown for A61P 17][IPC code unknown for A61P 17/02][IPC code unknown for A61P 19/02][IPC code unknown for A61P 25/04][IPC code unknown for A61P 29][IPC code unknown for A61P 35][IPC code unknown for A61P 37/06][IPC code unknown for A61P 43]
Applicants:
塩野義製薬株式会社 SHIONOGI & CO., LTD. [JP/JP]; 大阪府大阪市中央区道修町3丁目1番8号 1-8, Doshomachi 3-chome, Chuo-ku, Osaka-shi, Osaka 5410045, JP
Inventors:
舘野 佑介 TATENO, Yusuke; JP
Agent:
山内 秀晃 YAMAUCHI, Hideaki; JP
杉田 健一 SUGITA, Ken-ichi; JP
Priority Data:
2015-16634026.08.2015JP
Title (EN) 5-CARBONYLAMINOALKYL-SUBSTITUTED FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY
(FR) DÉRIVÉ DE PYRAZOLE CONDENSÉ SUBSTITUÉ PAR UN 5-CARBONYLAMINOALKYLE AYANT UNE ACTIVITÉ INHIBITRICE D'AUTOTAXINE
(JA) オートタキシン阻害活性を有する5位カルボニルアミノアルキル置換縮合ピラゾール誘導体
Abstract:
(EN) A compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, R1, R2a, R2b, R3, R4, R5, R9a, R9b, R10, R11, X, Y and Z are as defined in the description.)
(FR) L’invention concerne un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. (Dans la formule, R1, R2a, R2b, R3, R4, R5, R9a, R9b, R10, R11, X, Y et Z sont tels que définis dans la description).
(JA) 次式(I)の式で示される化合物またはその製薬上許容される塩:(式中、R、R2a、R2b、R、R、R、R9a、R9b、R10、R11、X、Y、およびZは明細書で定義した通りである)。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)